Catugal, Alexis John S.

HRN: 21-05-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
CEFUROXIME 750MG (VIAL)
05/13/2022
05/19/2022
IV
180
Q8 For 7 Days
Pneumonia
Waiting Final Action 
05/15/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/15/2022
05/22/2022
IV
70mg
Q24 For 7 Days
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: